echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Science sub-Journal accidentally found a way to eliminate super bacteria

    Science sub-Journal accidentally found a way to eliminate super bacteria

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Superbugs such as methicillin-resistant Staphylococcus aureus (MRSA) are now circulating in many hospitals in the United States, posing a serious public health threat and a global focus of disease control


    Scientists at Johns Hopkins University School of Medicine discovered by accident that full suppression of all caspases is a promising immunotherapy, which targets the host's immune system to fight MRSA and other bacterial skin infections


    The research published in the article in "Science Translational Medicine", "Pan-caspase inhibition as a potential host immunotherapy against MRSA and other bacterial skin infections" was funded by the National Institutes of Health (NIH), It is the basis of patent applications


    Lloyd Miller, MD, former professor of dermatology, infectious diseases and plastic surgery at Johns Hopkins University School of Medicine, now works for Janssen Research and Development, is here Senior author of the study

    "Alexander Fleming’s accidental discovery led to the golden age of antibiotics, but now the age of antibiotics is coming to an end due to the emergence of antibiotic-resistant bacteria," said Lloyd Miller, MD, a former Johns Hopkins Professor of Dermatology, Infectious Diseases and Plastic Surgery at the University School of Medicine


    Miller said that the initial focus of the research team was to study the mechanisms behind MRSA skin infections in mouse models that cannot synthesize interleukin-1β (IL-1β)


    Miller said: "We gave mice a blocker of all pancpasase inhibitors, a compound called Q-VD-OPH, and thought it would make two groups of mice [with and without IL] -1β] is more susceptible to MRSA infection


    In order to confirm that this accidental discovery was not accidental, but a viable method to suppress the deadly MRSA infection, Miller and his colleagues conducted other experiments with encouraging results


    A single oral dose of Q-VD-OPH reduces the size of methicillin-resistant Staphylococcus aureus skin lesions and quickly removes bacteria with vehicle-treated (considering that the operator solution does not have Q-VD-OPH) and untreated small Rats," said Martin Alfons, Ph.


    Alphonse said that Q-VD-OPH reduced the apoptosis of neutrophils and monocytes, making them abundant and better able to eliminate MRSA bacteria


    Miller said: "It's like a fire department.


    Studies have shown that in addition to increasing apoptosis, pancpasase inhibitors can also increase the necrosis of mature monocytes (also known as macrophages)


    Alphonse said: "Destroying macrophages through necrosis releases large amounts of TNF, a protein that triggers anti-bacterial immune cells to flood the infected area of ​​the skin


    The researchers tested whether Q-VD-OPH has broader activity in mice against two other dangerous skin bacteria-Streptococcus pyogenes and Pseudomonas aeruginosa


    Facts have proved that ubiquitin inhibitors target the human immune system to fight bacteria, and the effect of eliminating these two bacterial strains is as successful as the effect of eliminating MRSA


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.